CD8A and neoplasm: In a recent study, Garaude et al. demonstrated that introducing the bacterial protein flagellin, which activates TLR5, NAIP5, and NLRC4, into tumor-cell lines induced a potent CD8+ T cell anti-tumor adaptive immune response and thereby helped eliminate injected tumors.